Current Challenges for IDO2 as Target in Cancer Immunotherapy

Immune checkpoint inhibitors have revolutionized the clinical approach of untreatable tumors and brought a breath of fresh air in cancer immunotherapy. However, the therapeutic effects of these drugs only cover a minority of patients and alternative immunotherapeutic targets are required. Metabolism...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Mondanelli, Giada, Mandarano, Martina, Belladonna, Maria Laura, Suvieri, Chiara, Pelliccia, Cristina, Bellezza, Guido, Sidoni, Angelo, Carvalho, Agostinho, Grohmann, Ursula, Volpi, Claudia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097162/
https://ncbi.nlm.nih.gov/pubmed/33968089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.679953
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak